Keyphrases
African American
100%
Atrial Fibrillation
100%
Patients with Heart Failure
100%
Heart Failure Trials
100%
African American Patients
100%
Fixed-dose Combination
21%
Hydralazine
21%
Isosorbide Dinitrate
21%
Heart Failure
14%
Mortality Risk
14%
Brain Natriuretic Peptide
14%
Placebo
7%
Beta-blockers
7%
Quality of Life Assessment
7%
Angiotensin Receptor Blockers
7%
Creatinine
7%
New York Heart Association Class
7%
Low Blood Pressure
7%
Systolic Blood Pressure
7%
Diastolic Blood Pressure
7%
No Significant Difference
7%
Improved Survival
7%
Ejection Fraction
7%
Survival Benefit
7%
Neurohormonal Blockade
7%
Left Ventricular End-diastolic Diameter
7%
Low Enrollment
7%
Creatinine Level
7%
Systolic Heart Failure
7%
Reviewer Characteristics
7%
Angiotensin-converting Enzyme Inhibitor (ACEi)
7%
Little Data
7%
Immunology and Microbiology
Blood Pressure
100%
Systolic Blood Pressure
100%
Diastolic Blood Pressure
100%
Heart Left Ventricle Ejection Fraction
100%
Medicine and Dentistry
Atrial Fibrillation
100%
Congestive Heart Failure
100%
Isosorbide Dinitrate
21%
Hydralazine
21%
Creatinine
14%
Brain Natriuretic Peptide
14%
Quality of Life
7%
New York Heart Association Class
7%
Hypotension
7%
Angiotensin Receptor Antagonist
7%
Heart Left Ventricle Ejection Fraction
7%
ACE Inhibitor
7%
Diastolic Blood Pressure
7%
Systolic Blood Pressure
7%
Post-Hoc Analysis
7%
Systolic Heart Failure
7%
Placebo
7%
Nursing and Health Professions
Congestive Heart Failure
100%
Atrial Fibrillation
100%
Isosorbide Dinitrate/Hydralazine
21%
Creatinine
14%
Brain Natriuretic Peptide
14%
Quality of Life
7%
Dipeptidyl Carboxypeptidase Inhibitor
7%
Post Hoc Analysis
7%
Placebo
7%
Systolic Blood Pressure
7%
New York Heart Association Class
7%
Diastolic Blood Pressure
7%
Hypotension
7%
Heart Left Ventricle Ejection Fraction
7%
Angiotensin Receptor Antagonist
7%
Systolic Heart Failure
7%
Pharmacology, Toxicology and Pharmaceutical Science
Congestive Heart Failure
100%
Atrial Fibrillation
100%
Hydralazine
21%
Isosorbide Dinitrate
21%
Creatinine
14%
Brain Natriuretic Peptide
14%
Placebo
7%
Angiotensin Receptor Antagonist
7%
Dipeptidyl Carboxypeptidase Inhibitor
7%
Hypotension
7%
Systolic Heart Failure
7%
Neuroscience
Atrial Fibrillation
100%
Isosorbide Dinitrate/Hydralazine
21%
Creatinine
14%
Brain Natriuretic Peptide
14%
Angiotensin Receptor
7%
Placebo
7%
ACE Inhibitor
7%